Safety and tolerability of mRNA COVID-19 vaccines in people with antiphospholipid antibodies.
作者信息
Sciascia Savino, Costanzo Piera, Radin Massimo, Schreiber Karen, Pini Massimo, Vaccarino Antonella, Cecchi Irene, Baldovino Simone, Roccatello Dario
机构信息
CMID-Nephrology and Dialysis Unit (ERK-net member), Research Center of Immunopathology, Coordinating Center of the Network for Rare Diseases of Piedmont and Aosta Valley, San Giovanni Bosco Hub Hospital, 10154 Turin, Italy.
Department of Clinical and Biological Sciences, University of Turin, Turin, Italy.
出版信息
Lancet Rheumatol. 2021 Dec;3(12):e832. doi: 10.1016/S2665-9913(21)00320-9. Epub 2021 Oct 20.
Abstract
摘要
相似文献
1
Safety and tolerability of mRNA COVID-19 vaccines in people with antiphospholipid antibodies.抗磷脂抗体人群中mRNA新冠疫苗的安全性和耐受性。
Lancet Rheumatol. 2021 Dec;3(12):e832. doi: 10.1016/S2665-9913(21)00320-9. Epub 2021 Oct 20.
2
Efficacy, Immunogenicity and Safety of COVID-19 Vaccines: A Systematic Review and Meta-Analysis.新型冠状病毒肺炎疫苗的有效性、免疫原性和安全性的系统评价和荟萃分析。
Front Immunol. 2021 Oct 11;12:714170. doi: 10.3389/fimmu.2021.714170. eCollection 2021.
3
Safety and tolerability of the novel 2019 coronavirus disease (COVID-19) vaccines among people with epilepsy (PwE): A cross-sectional study.新型 2019 冠状病毒病（COVID-19）疫苗在癫痫患者（PwE）中的安全性和耐受性：一项横断面研究。
Seizure. 2021 Nov;92:2-9. doi: 10.1016/j.seizure.2021.08.001. Epub 2021 Aug 6.
4
Prevalence and clinical significance of antiphospholipid antibodies in patients with coronavirus disease 2019 admitted to intensive care units: a prospective observational study.COVID-19 患者入住重症监护病房时抗磷脂抗体的流行率和临床意义：一项前瞻性观察研究。
Rheumatol Int. 2021 Jul;41(7):1243-1252. doi: 10.1007/s00296-021-04875-7. Epub 2021 May 5.
5
Mini Review Immunological Consequences of Immunization With COVID-19 mRNA Vaccines: Preliminary Results.综述：接种 COVID-19 mRNA 疫苗的免疫后果：初步结果。
Front Immunol. 2021 Mar 12;12:657711. doi: 10.3389/fimmu.2021.657711. eCollection 2021.
6
The Rapid Development and Early Success of Covid 19 Vaccines Have Raised Hopes for Accelerating the Cancer Treatment Mechanism.新冠疫苗的快速研发和早期成功为加速癌症治疗机制带来了希望。
Arch Razi Inst. 2021 Mar;76(1):1-6. doi: 10.22092/ari.2021.353761.1612. Epub 2021 Mar 1.
7
Efficacy and Safety of COVID-19 Vaccines in Phase III Trials: A Meta-Analysis.新冠病毒疫苗Ⅲ期试验的疗效与安全性：一项荟萃分析
Vaccines (Basel). 2021 Jun 1;9(6):582. doi: 10.3390/vaccines9060582.
8
Positive aspects of the mRNA platform for SARS-CoV-2 vaccines.mRNA 平台在 SARS-CoV-2 疫苗方面的积极方面。
Hum Vaccin Immunother. 2021 Aug 3;17(8):2445-2447. doi: 10.1080/21645515.2021.1900713. Epub 2021 Apr 8.
9
Antiphospholipid Antibodies and Infection: .抗磷脂抗体与感染： 。
Front Immunol. 2021 Jun 16;12:687534. doi: 10.3389/fimmu.2021.687534. eCollection 2021.
10
Induction of High Levels of Specific Humoral and Cellular Responses to SARS-CoV-2 After the Administration of Covid-19 mRNA Vaccines Requires Several Days.接种 COVID-19 mRNA 疫苗后，需要数天才能诱导针对 SARS-CoV-2 的高特异性体液和细胞反应。
Front Immunol. 2021 Oct 4;12:726960. doi: 10.3389/fimmu.2021.726960. eCollection 2021.
引用本文的文献
1
Characteristics of Oral Adverse Effects following COVID-19 Vaccination and Similarities with Oral Symptoms in COVID-19 Patients: Taste and Saliva Secretory Disorders.新型冠状病毒肺炎疫苗接种后口腔不良反应的特征以及与新型冠状病毒肺炎患者口腔症状的相似性：味觉和唾液分泌障碍
Med Princ Pract. 2025;34(2):101-120. doi: 10.1159/000543182. Epub 2024 Dec 19.
2
Antiphospholipid syndrome, thrombosis, and vaccination in the COVID-19 pandemic.抗磷脂综合征、血栓形成与 COVID-19 大流行中的疫苗接种。
Rheumatol Int. 2024 May;44(5):749-755. doi: 10.1007/s00296-023-05531-y. Epub 2024 Feb 23.
3
COVID-19 and antiphospholipid antibodies.COVID-19 与抗磷脂抗体。
Best Pract Res Clin Haematol. 2022 Sep;35(3):101402. doi: 10.1016/j.beha.2022.101402. Epub 2022 Oct 15.
4
Safety and tolerance of vaccines against SARS-CoV-2 infection in systemic lupus erythematosus: results from the COVAD study.系统性红斑狼疮患者感染 SARS-CoV-2 疫苗的安全性和耐受性：COVAD 研究结果。
Rheumatology (Oxford). 2023 Jul 5;62(7):2453-2463. doi: 10.1093/rheumatology/keac661.
5
Evaluation of patients with antiphospholipid syndrome subsequently COVID-19 vaccinations: A retrospective cohort study.抗磷脂综合征患者接种 COVID-19 疫苗后的评估：一项回顾性队列研究。
Int J Rheum Dis. 2023 Feb;26(2):292-297. doi: 10.1111/1756-185X.14490. Epub 2022 Nov 12.
6
The Impact of Anti-SARS-CoV-2 Vaccine in Patients with Systemic Lupus Erythematosus: A Multicentre Cohort Study.抗SARS-CoV-2疫苗对系统性红斑狼疮患者的影响：一项多中心队列研究
Vaccines (Basel). 2022 Apr 22;10(5):663. doi: 10.3390/vaccines10050663.
7
Immunogenicity, Effectiveness, and Safety of COVID-19 Vaccines in Rheumatic Patients: An Updated Systematic Review and Meta-Analysis.新冠疫苗在风湿性疾病患者中的免疫原性、有效性和安全性：一项更新的系统评价与荟萃分析
Biomedicines. 2022 Apr 1;10(4):834. doi: 10.3390/biomedicines10040834.
8
Anti-prothrombin autoantibodies enriched after infection with SARS-CoV-2 and influenced by strength of antibody response against SARS-CoV-2 proteins.感染 SARS-CoV-2 后可富集抗凝血酶原自身抗体，并受针对 SARS-CoV-2 蛋白的抗体反应强度影响。
PLoS Pathog. 2021 Dec 3;17(12):e1010118. doi: 10.1371/journal.ppat.1010118. eCollection 2021 Dec.
本文引用的文献
1
Surveillance for Adverse Events After COVID-19 mRNA Vaccination.COVID-19 mRNA 疫苗接种后不良事件的监测。
JAMA. 2021 Oct 12;326(14):1390-1399. doi: 10.1001/jama.2021.15072.
2
Antibody development after COVID-19 vaccination in patients with autoimmune diseases in the Netherlands: a substudy of data from two prospective cohort studies.荷兰自身免疫性疾病患者接种新冠疫苗后的抗体产生情况：两项前瞻性队列研究数据的子研究
Lancet Rheumatol. 2021 Nov;3(11):e778-e788. doi: 10.1016/S2665-9913(21)00222-8. Epub 2021 Aug 6.
3
Preliminary Data on Post Market Safety Profiles of COVID 19 Vaccines in Rheumatic Diseases: Assessments on Various Vaccines in Use, Different Rheumatic Disease Subtypes, and Immunosuppressive Therapies: A Two-Centers Study.新冠疫苗在风湿性疾病中的上市后安全性概况的初步数据：对各种正在使用的疫苗、不同风湿性疾病亚型以及免疫抑制疗法的评估：一项双中心研究
Vaccines (Basel). 2021 Jul 2;9(7):730. doi: 10.3390/vaccines9070730.
4
Immunogenicity and safety of the CoronaVac inactivated vaccine in patients with autoimmune rheumatic diseases: a phase 4 trial.CoronaVac 灭活疫苗在自身免疫性风湿病患者中的免疫原性和安全性：一项 4 期临床试验。
Nat Med. 2021 Oct;27(10):1744-1751. doi: 10.1038/s41591-021-01469-5. Epub 2021 Jul 30.
5
Antiphospholipid Antibodies and Infection: .抗磷脂抗体与感染： 。
Front Immunol. 2021 Jun 16;12:687534. doi: 10.3389/fimmu.2021.687534. eCollection 2021.
Zotero 插件